These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Involvement of calpain activation in neurodegenerative processes. Camins A; Verdaguer E; Folch J; Pallàs M CNS Drug Rev; 2006; 12(2):135-48. PubMed ID: 16958987 [TBL] [Abstract][Full Text] [Related]
4. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. Raynaud F; Marcilhac A FEBS J; 2006 Aug; 273(15):3437-43. PubMed ID: 16884489 [TBL] [Abstract][Full Text] [Related]
5. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Nixon RA; Saito KI; Grynspan F; Griffin WR; Katayama S; Honda T; Mohan PS; Shea TB; Beermann M Ann N Y Acad Sci; 1994 Dec; 747():77-91. PubMed ID: 7847693 [TBL] [Abstract][Full Text] [Related]
7. Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium. Camins A; Crespo-Biel N; Junyent F; Verdaguer E; Canudas AM; Pallàs M Curr Drug Metab; 2009 Jun; 10(5):433-47. PubMed ID: 19689241 [TBL] [Abstract][Full Text] [Related]
9. The calpains in aging and aging-related diseases. Nixon RA Ageing Res Rev; 2003 Oct; 2(4):407-18. PubMed ID: 14522243 [TBL] [Abstract][Full Text] [Related]
10. Calpain-2 as a therapeutic target for acute neuronal injury. Wang Y; Bi X; Baudry M Expert Opin Ther Targets; 2018 Jan; 22(1):19-29. PubMed ID: 29168923 [TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide and calpain activation in neuronal death and survival. Araújo IM; Carvalho CM Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):319-24. PubMed ID: 16101551 [TBL] [Abstract][Full Text] [Related]
12. The calcium-dependent protease calpain in neuronal remodeling and neurodegeneration. Metwally E; Zhao G; Zhang YQ Trends Neurosci; 2021 Sep; 44(9):741-752. PubMed ID: 34417060 [TBL] [Abstract][Full Text] [Related]
13. Targeting calpain in synaptic plasticity. Baudry M; Chou MM; Bi X Expert Opin Ther Targets; 2013 May; 17(5):579-92. PubMed ID: 23379852 [TBL] [Abstract][Full Text] [Related]
14. Calpains as mechanistic drivers and therapeutic targets for ocular disease. Vu JT; Wang E; Wu J; Sun YJ; Velez G; Bassuk AG; Lee SH; Mahajan VB Trends Mol Med; 2022 Aug; 28(8):644-661. PubMed ID: 35641420 [TBL] [Abstract][Full Text] [Related]
15. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. Higuchi M; Tomioka M; Takano J; Shirotani K; Iwata N; Masumoto H; Maki M; Itohara S; Saido TC J Biol Chem; 2005 Apr; 280(15):15229-37. PubMed ID: 15699033 [TBL] [Abstract][Full Text] [Related]
16. Implications of calpains in health and diseases. Chakraborti S; Alam MN; Paik D; Shaikh S; Chakraborti T Indian J Biochem Biophys; 2012 Oct; 49(5):316-28. PubMed ID: 23259318 [TBL] [Abstract][Full Text] [Related]
17. Caspase and calpain substrates: roles in synaptic plasticity and cell death. Chan SL; Mattson MP J Neurosci Res; 1999 Oct; 58(1):167-90. PubMed ID: 10491581 [TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of the calpain family: new aspects. Saez ME; Ramirez-Lorca R; Moron FJ; Ruiz A Drug Discov Today; 2006 Oct; 11(19-20):917-23. PubMed ID: 16997142 [TBL] [Abstract][Full Text] [Related]